바이오젠(주)
MX ˙ BMV ˙ US09062X1037
SecurityMX:BIIB / Biogen Inc.
InstitutionTcw Group Inc
Latest Disclosed Ownership2,338 shares
Latest Disclosed Value $ 428,626
Tcw Group Inc reports 5.03% increase in ownership of BIIB / Biogen Inc.

On May 14, 2026 - Tcw Group Inc filed a 13F-HR form disclosing ownership of 2,338 shares of Biogen Inc. (MX:BIIB) valued at $428,626 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,226 shares of Biogen Inc.. This represents a change in shares of 5.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOGEN COM 09062X103 2,338 112 5.03 429 9.46 0.0032
2026-02-17 2025-12-31 13F BIOGEN COM 09062X103 2,226 2,226 392 0.0028
2017-05-11 2017-03-31 13F BIOGEN COM 09062X103 0 -21,850 -100.00 0 -100.00
2017-02-10 2016-12-31 13F BIOGEN COM 09062X103 21,850 1,953 9.82 6,196 -0.51 0.0466
2016-11-14 2016-09-30 13F BIOGEN COM 09062X103 19,897 -1,400 -6.57 6,228 20.93 0.0473
2016-08-12 2016-06-30 13F/A-1 BIOGEN COM 09062X103 21,297 1,493 7.54 5,150 -0.10 0.0389
2016-08-11 2016-06-30 13F BIOGEN COM 09062X103 21,297 5,150
2016-05-16 2016-03-31 13F BIOGEN COM 09062X103 19,804 -200 -1.00 5,155 -15.88 0.0378
2016-02-16 2015-12-31 13F BIOGEN COM 09062X103 20,004 654 3.38 6,128 8.52 0.0440
2015-11-13 2015-09-30 13F BIOGEN COM 09062X103 19,350 -650 -3.25 5,647 -30.10 0.0405
2015-08-12 2015-06-30 13F BIOGEN COM 09062X103 20,000 -50,259 -71.53 8,079 -72.77 0.0520
2015-05-13 2015-03-31 13F BIOGEN COM 09062X103 70,259 2,009 2.94 29,666 28.05 0.1424
2015-02-13 2014-12-31 13F BIOGEN IDEC COM 09062X103 68,250 -49,450 -42.01 23,167 -40.50 0.0969
2014-11-14 2014-09-30 13F BIOGEN IDEC COM 09062X103 117,700 -2,450 -2.04 38,936 2.78 0.1566
2014-08-14 2014-06-30 13F BIOGEN IDEC COM 09062X103 120,150 1,350 1.14 37,884 4.26 0.1560
2014-05-13 2014-03-31 13F BIOGEN IDEC COM 09062X103 118,800 -800 -0.67 36,337 8.63 0.1509
2014-02-18 2013-12-31 13F/A-1 BIOGEN IDEC COM 09062X103 119,600 -550 -0.46 33,449 15.63 0.1410
2014-02-14 2013-12-31 13F BIOGEN IDEC COM 09062X103 33,449 119,600
2013-11-14 2013-09-30 13F BIOGEN IDEC COM 09062X103 120,150 1,032 0.87 28,927 12.85 0.1336
2013-08-14 2013-06-30 13F/A-1 BIOGEN IDEC COM 09062X103 119,118 119,118 25,634 0.1264
2013-08-14 2013-06-30 13F BIOGEN IDEC COM 09062X103 119,118 25,634
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.